In Figure 1, peripheral blood collected from the AML patients showed that the AML patient group (n = 20) had a markedly decreased plasma IL-1β level (10.0-fold) and an increased plasma IL-6 level (72.6-fold) as compared to the healthy volunteers (n = 20). This evidence concerns the gene IL1B and acute myeloid leukemia.